297 related articles for article (PubMed ID: 10897675)
1. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
[TBL] [Abstract][Full Text] [Related]
4. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia].
Honda Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():181-5. PubMed ID: 9216212
[TBL] [Abstract][Full Text] [Related]
8. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
[TBL] [Abstract][Full Text] [Related]
9. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of levels of lung surfactant protein A in serum, in various lung diseases].
Abe S; Honda Y; Ando M; Saita N; Kida K; Jinno S; Kondo A; Kuroki Y; Akino T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1219-25. PubMed ID: 8583713
[TBL] [Abstract][Full Text] [Related]
12. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
[TBL] [Abstract][Full Text] [Related]
13. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
Kohno N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
[TBL] [Abstract][Full Text] [Related]
14. [Surfactant proteins A and D as biomarkers of disease activity in diffuse interstitial pneumonia].
Abe S; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):157-65. PubMed ID: 10846395
[TBL] [Abstract][Full Text] [Related]
15. [The usefulness of serum KL-6 levels for the diagnosis of disease activity in idiopathic interstitial pneumonia].
Totani Y; Demura Y; Ameshima S; Ishizaki T; Miyamori I
Nihon Kokyuki Gakkai Zasshi; 2000 Jun; 38(6):437-41. PubMed ID: 10979280
[TBL] [Abstract][Full Text] [Related]
16. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
Kohno N
J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
[TBL] [Abstract][Full Text] [Related]
17. Surfactant protein D and KL-6 as serologic indicators of Pneumocystis carinii pneumonia in a child with acute lymphoblastic leukemia.
Takahashi T; Ebihara Y; Manabe A; Tsuji K; Nakamura T; Nakahata T; Iwamoto A
J Med; 2001; 32(1-2):41-51. PubMed ID: 11321887
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
[TBL] [Abstract][Full Text] [Related]
19. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia].
Kobayashi J; Itoh Y; Kitamura S; Kawai T
Rinsho Byori; 1996 Jul; 44(7):653-8. PubMed ID: 8801361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
